Japanese Guideline of Bioequivalence [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2021-02-24 19:07 (712 d 20:15 ago) – Posting: # 22234
Views: 961

Hi Brus,

❝ I have consulted the Japanese Bioequivalence guideline and I have not seen this mention. Where does this requirement come from? Where does it appear in the guideline or legislation?


You are aware that you are referring to a post which is whopping eleven years old?
The last time I’ve heard about this requirement was at the ‘EUFEPS/BABP Network Open Discussion Forum’ (Barcelona, 23/24 February 2011).
The Japanese guideline is of 2012…

[image] The Times They Are A-Changin’

If in doubt, see there. ;-)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
20 visitors (0 registered, 20 guests [including 10 identified bots]).
Forum time: 15:22 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5